Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic.
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Basic Reproduction Number
/ statistics & numerical data
Burkina Faso
/ epidemiology
COVID-19
/ epidemiology
Child
Child, Preschool
Communicable Disease Control
/ methods
Computational Biology
Contact Tracing
/ methods
Female
France
/ epidemiology
Humans
Infant
Infant, Newborn
Male
Mathematical Concepts
Middle Aged
Models, Biological
Models, Statistical
Pandemics
/ prevention & control
Physical Distancing
SARS-CoV-2
Vietnam
/ epidemiology
Young Adult
Journal
PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
26
11
2020
accepted:
07
02
2021
revised:
16
03
2021
pubmed:
5
3
2021
medline:
26
3
2021
entrez:
4
3
2021
Statut:
epublish
Résumé
In an epidemic, individuals can widely differ in the way they spread the infection depending on their age or on the number of days they have been infected for. In the absence of pharmaceutical interventions such as a vaccine or treatment, non-pharmaceutical interventions (e.g. physical or social distancing) are essential to mitigate the pandemic. We develop an original approach to identify the optimal age-stratified control strategy to implement as a function of the time since the onset of the epidemic. This is based on a model with a double continuous structure in terms of host age and time since infection. By applying optimal control theory to this model, we identify a solution that minimizes deaths and costs associated with the implementation of the control strategy itself. We also implement this strategy for three countries with contrasted age distributions (Burkina-Faso, France, and Vietnam). Overall, the optimal strategy varies throughout the epidemic, with a more intense control early on, and depending on host age, with a stronger control for the older population, except in the scenario where the cost associated with the control is low. In the latter scenario, we find strong differences across countries because the control extends to the younger population for France and Vietnam 2 to 3 months after the onset of the epidemic, but not for Burkina Faso. Finally, we show that the optimal control strategy strongly outperforms a constant uniform control exerted over the whole population or over its younger fraction. This improved understanding of the effect of age-based control interventions opens new perspectives for the field, especially for age-based contact tracing.
Identifiants
pubmed: 33661890
doi: 10.1371/journal.pcbi.1008776
pii: PCOMPBIOL-D-20-02129
pmc: PMC7963091
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008776Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
PLoS Comput Biol. 2012;8(3):e1002425
pubmed: 22412366
Math Biosci Eng. 2019 Aug 16;16(6):7477-7493
pubmed: 31698624
Math Biosci Eng. 2012 Oct;9(4):819-41
pubmed: 23311424
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nature. 2020 Apr;580(7803):316-318
pubmed: 32242115
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
Epidemics. 2015 Mar;10:58-62
pubmed: 25843385
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Math Biosci. 2006 May;201(1-2):15-47
pubmed: 16466752
BMC Infect Dis. 2010 Feb 19;10:32
pubmed: 20170501
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
Math Biosci Eng. 2013 Oct-Dec;10(5-6):1615-34
pubmed: 24245639
J Math Ind. 2020;10(1):23
pubmed: 32834921
Science. 2020 May 8;368(6491):
pubmed: 32234805
N Engl J Med. 2020 Aug 27;383(9):885-886
pubmed: 32530584
J Math Biol. 2016 Aug;73(2):305-33
pubmed: 26676356
J Math Biol. 1990;28(4):411-34
pubmed: 2384720
Am J Epidemiol. 2005 Oct 1;162(7):686-93
pubmed: 16107568
Int J Infect Dis. 2004 Jul;8(4):227-35
pubmed: 15234327
J Math Biol. 1985;22(1):117-20
pubmed: 3926925
Math Biosci Eng. 2015 Feb;12(1):23-40
pubmed: 25811330
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Bull Math Biol. 2020 Sep 4;82(9):118
pubmed: 32888118